• HOME
• ABOUT MaRS
• THE MaRS CENTRE
• MaRS SERVICES
• EVENTS
• NEWS
• RECOMMENDED RESOURCES

• MaRS Event Series
• Reserve Meeting & Event Space

SESSION THEMES Financing research and development is always a challenge, however R&D can play an important role in a company’s growth. Take advantage of this opportunity to learn more about the Government of Canada’s Scientific Research & Experimental Development (SR&ED) program and how you can best use the program to support your industrial research and development projects. The session will feature Dr. Lynda Sturgeoff, Research and Technology Manager of Canada Revenue Agency, speaking on the SR&ED program. You will also have the opportunity to gather information on other Government of Canada programs of interest to technology and life sciences firms. Meet with Government of Canada officials representing a wide range of federals services for business for more information on what programs might benefit your company. Dr. Tony Cruz of Transition Therapeutics, one of the biotech companies located at MaRS, will be joining to share an entrepreneur's perspective on use of the program.

DATE | TIME | LOCATION

LEARNING OBJECTIVES

• Overview of the SR&ED program, application process, sequence of events, how to best use the program to meet some of your research needs
• Gather targeted information on Government of Canada programs of interest to ICT and Life Sciences firms
• Meet with Government of Canada officials representing a wide range of federal services for business to learn about which programs and services may be right for your firm

ABOUT THE SPEAKERS

This session is presented by Industry Canada's SR&ED program

About SR&ED

The Scientific Research and Experimental Development (SR&ED) program is a federal tax incentive program to encourage Canadian businesses of all sizes and in all sectors to conduct research and development (R&D) in Canada that will lead to new, improved, or technologically advanced products or processes. The SR&ED program is the largest single source of federal government support for industrial research and development.

Claimants can apply for SR&ED investment tax credits for expenditures such as wages, materials, machinery, equipment, some overhead, and SR&ED contracts.

About Dr. Lynda Sturgeoff

Dr. Lynda Sturgeoff, a native Torontonian and University of Toronto alumna, obtained her Ph.D. in Chemistry from MIT in 1982. Her research in organometallic synthesis was conducted under the direction of Professor Richard Schrock, who was awarded the Nobel Prize in chemistry in 2005.

Lynda spent close to 20 years leading and managing chemical research, both in academia and industry. She joined the Canada Revenue Agency in 2001 as a Research & Technology Manager with the Scientific Research & Experimental Development (SR&ED) Division, in the Toronto Centre Tax Services Office. Lynda and her team of 12 scientists and engineers are responsible for SR&ED claims in a wide range of industry sectors, including the biosciences, food, chemicals, materials, automotive and aerospace amongst others.

About Dr. Tony Cruz

Dr. Cruz is one of the founders of Transition Therapeutics and has held the position of Chief Executive Officer of Transition Therapeutics since its inception in July 1998. He was a Co-Founder, Vice-President and Director at Angiotech Pharmaceuticals Inc. He has been a Senior Scientist at Mount Sinai Hospital since 1995 and was the CEO and President of the Canadian Arthritis Network until 2001. He has also served as a consultant for biotechnology companies and investment firms.

MORE INFORMATION

• Email Page
• Print Page
• Increase Font
• Decrease Font

MaRS PICKS

Read more

See more picks

See more picks

• MaRS Centre, South Tower, 101 College Street, Suite 100
• Toronto, ON Canada M5G 1L7
• T 416.673.8100F 416.673.8181E marsdiscoverydistrict@marsdd.com

• Copyright 2007 MaRS Discovery District. All rights reserved.


• Contact MaRS
• Site Map
• Privacy Policy
• Terms and Conditions